D. Horne

Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.

J. Rodis, P. Benn, A. Craffey, 2000, The Journal of maternal-fetal medicine.

Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography.

A. Borgida, J. Rodis, P. Benn, 1997, American journal of obstetrics and gynecology.

Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome

J. Rodis, P. Benn, A. Craffey, 2000 .

Maternal serum screening for fetal trisomy 18: a comparison of fixed cutoff and patient-specific risk protocols.

J. Rodis, P. Benn, T. Beazoglou, 1999, Obstetrics and gynecology.

Incorporation of Inhibin‐A in Second‐Trimester Screening for Down Syndrome

J. Egan, P. Benn, M. Fang, 2003, Obstetrics and gynecology.

Elevated Second‐Trimester Maternal Serum hCG Alone or in Combination With Elevated Alpha‐Fetoprotein

J. Clive, J. Rodis, P. Benn, 1996, Obstetrics and gynecology.

Maternal serum screening for birth defects: results of a Connecticut regional program.

R. Greenstein, P. Benn, A. Craffey, 1996, Connecticut medicine.

Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.

R. Greenstein, P. Benn, P. Benn, 1995, American journal of obstetrics and gynecology.